Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenzo Castiglione

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
European Journal of Internal Medicine|September 26, 2025
Serum transthyretin in ATTR-CM: A pragmatic biomarker edging toward prime timeAlberto Aimo, Vincenzo Castiglione, Giuseppe Vergaro
European Journal of Preventive Cardiology|June 1, 2026
Cardiac Troponins and SARS-CoV-2: Subclinical Myocardial Injury as he Long Shadow of the PandemicVincenzo Castiglione, Aldo Clerico, Michele Emdin
European Heart Journal. Quality of Care & Clinical Outcomes|May 23, 2026
Beyond body mass index: consistent benefits of SGLT2 inhibitors and the limits of a convenient metricMartina Chiriacò, Vincenzo Castiglione, Michele Emdin
European Journal of Heart Failure|April 21, 2022
Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it isMichele Emdin, Alberto Aimo, Vincenzo Castiglione
International Journal of Cardiology|June 26, 2023
Cachexia, sarcopenia and heart failure: A last mile to be walkedVincenzo Castiglione, Francesco Gentile, Giuseppe Vergaro
International Journal of Cardiology|February 15, 2024
Cost-effectiveness of transthyretin cardiac amyloidosis screening and treatment: A Dilemma for the clinicianVincenzo Castiglione, Alberto Aimo, Giuseppe Vergaro
European Heart Journal Open|September 22, 2025
Myocardial deformation imaging to monitor treatment response in AL amyloidosis: is it worth the strain?Vincenzo Castiglione, Francesco Gentile, Giuseppe Vergaro
International Journal of Cardiology|April 20, 2022
Targeting precipitants to prevent heart failure hospitalization. Does season matter?Vincenzo Castiglione, Giuseppe Vergaro, Michele Emdin
European Heart Journal. Quality of Care & Clinical Outcomes|January 28, 2026
Acetazolamide for Acute Heart Failure: Rethinking Clinical and Economic Value in a Field of Narrow GainsVincenzo Castiglione, Francesco Gentile, Michele Emdin
European Journal of Heart Failure|June 19, 2022
Do we need to EVALUATE multiple biomarkers and/or the same biomarkers multiple times in patients with heart failure?Alberto Aimo, Vincenzo Castiglione, Antoni Bayes-Genis
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
European Journal of Internal Medicine|September 26, 2025
Serum transthyretin in ATTR-CM: A pragmatic biomarker edging toward prime timeAlberto Aimo, Vincenzo Castiglione, Giuseppe Vergaro
European Journal of Preventive Cardiology|June 1, 2026
Cardiac Troponins and SARS-CoV-2: Subclinical Myocardial Injury as he Long Shadow of the PandemicVincenzo Castiglione, Aldo Clerico, Michele Emdin
European Heart Journal. Quality of Care & Clinical Outcomes|May 23, 2026
Beyond body mass index: consistent benefits of SGLT2 inhibitors and the limits of a convenient metricMartina Chiriacò, Vincenzo Castiglione, Michele Emdin
European Journal of Heart Failure|April 21, 2022
Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it isMichele Emdin, Alberto Aimo, Vincenzo Castiglione
International Journal of Cardiology|June 26, 2023
Cachexia, sarcopenia and heart failure: A last mile to be walkedVincenzo Castiglione, Francesco Gentile, Giuseppe Vergaro
International Journal of Cardiology|February 15, 2024
Cost-effectiveness of transthyretin cardiac amyloidosis screening and treatment: A Dilemma for the clinicianVincenzo Castiglione, Alberto Aimo, Giuseppe Vergaro
European Heart Journal Open|September 22, 2025
Myocardial deformation imaging to monitor treatment response in AL amyloidosis: is it worth the strain?Vincenzo Castiglione, Francesco Gentile, Giuseppe Vergaro
International Journal of Cardiology|April 20, 2022
Targeting precipitants to prevent heart failure hospitalization. Does season matter?Vincenzo Castiglione, Giuseppe Vergaro, Michele Emdin
European Heart Journal. Quality of Care & Clinical Outcomes|January 28, 2026
Acetazolamide for Acute Heart Failure: Rethinking Clinical and Economic Value in a Field of Narrow GainsVincenzo Castiglione, Francesco Gentile, Michele Emdin
European Journal of Heart Failure|June 19, 2022
Do we need to EVALUATE multiple biomarkers and/or the same biomarkers multiple times in patients with heart failure?Alberto Aimo, Vincenzo Castiglione, Antoni Bayes-Genis
Pageof 14